Antimicrobial de-escalation in cancer patients

被引：2
|
作者：
Rolston, K. V. I. [1 ]
Mahajan, S. N. [1 ]
Chemaly, R. F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Unit 1460, Houston, TX 77030 USA
来源：
INFECTION | 2012年 / 40卷 / 02期
关键词：
INFECTIOUS-DISEASES SOCIETY; AMERICA; RESISTANT; UPDATE;
D O I：
10.1007/s15010-011-0221-6
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：223 / 224
页数：2
相关论文
共 50 条
  • [1] Antimicrobial De-Escalation in Critically Ill Patients
    Tanzarella, Eloisa Sofia
    Cutuli, Salvatore Lucio
    Lombardi, Gianmarco
    Cammarota, Fabiola
    Caroli, Alessandro
    Franchini, Emanuele
    Sancho Ferrando, Elena
    Grieco, Domenico Luca
    Antonelli, Massimo
    De Pascale, Gennaro
    ANTIBIOTICS-BASEL, 2024, 13 (04):
  • [2] Efficacy and safety of antimicrobial de-escalation as a clinical strategy
    Mathieu, Calypso
    Pastene, Bruno
    Cassir, Nadim
    Martin-Loeches, Ignacio
    Leone, Marc
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (02) : 79 - 88
  • [3] Breast Cancer Screening: Is There Room for De-escalation?
    Kim, Leah S.
    Lannin, Donald R.
    CURRENT BREAST CANCER REPORTS, 2022, 14 (04) : 153 - 161
  • [4] Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs
    Hughes, Josie
    Huo, Xi
    Falk, Lindsey
    Hurford, Amy
    Lan, Kunquan
    Coburn, Bryan
    Morris, Andrew
    Wu, Jianhong
    PLOS ONE, 2017, 12 (02):
  • [5] Antibiotic De-Escalation in Critically Ill Patients with Negative Clinical Cultures
    Roper, Spencer
    Wingler, Mary Joyce B.
    Cretella, David A.
    PHARMACY, 2023, 11 (03)
  • [6] Why is antimicrobial de-escalation under-prescribed for urinary tract infections?
    Duchene, E.
    Montassier, E.
    Boutoille, D.
    Caillon, J.
    Potel, G.
    Batard, E.
    INFECTION, 2013, 41 (01) : 211 - 214
  • [7] De-escalation from Echinocandins to Azole Treatment in Critically Ill Patients with Candidemia
    Lin, Jing
    Zhou, Menglan
    Chen, Jialong
    Zhang, Li
    Lu, Minya
    Liu, Zhengyin
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 121 : 69 - 74
  • [8] Outcomes Associated With Antimicrobial De-escalation of Treatment for Pneumonia Within the Veterans Healthcare Administration
    Bohan, Jefferson G.
    Remington, Richard
    Jones, Makoto
    Samore, Matthew
    Madaras-Kelly, Karl
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [9] Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting
    Lew, Kaung Yuan
    Ng, Tat Ming
    Tan, Michelle
    Tan, Sock Hoon
    Lew, Ee Ling
    Ling, Li Min
    Ang, Brenda
    Lye, David
    Teng, Christine B.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (04) : 1219 - 1225
  • [10] Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin
    Petteys, Megan M.
    Kachur, Ekaterina
    Pillinger, Kelly E.
    He, Jiaxian
    Copelan, Edward A.
    Shahid, Zainab
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (03) : 632 - 640
12345